Citadel Advisors’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-98,100
| Closed | -$1.79M | – | 13340 |
|
|
2025
Q3 | $1.79M | Buy |
98,100
+4,700
| +5% | +$91.6K | ﹤0.01% | 6302 |
|
|
2025
Q2 | $1.88M | Buy |
93,400
+91,000
| +3,792% | +$1.75M | ﹤0.01% | 5813 |
|
|
2025
Q1 | $43.5K | Buy |
2,400
+1,600
| +200% | +$28.7K | ﹤0.01% | 12447 |
|
|
2024
Q4 | $13.9K | Buy |
800
+500
| +167% | +$9.6K | ﹤0.01% | 13425 |
|
|
2024
Q3 | $5.79K | Sell |
300
-5,100
| -94% | -$94K | ﹤0.01% | 13462 |
|
|
2024
Q2 | $88.6K | Sell |
5,400
-8,700
| -62% | -$135K | ﹤0.01% | 11086 |
|
|
2024
Q1 | $215K | Buy |
14,100
+2,400
| +21% | +$37.7K | ﹤0.01% | 10164 |
|
|
2023
Q4 | $188K | Sell |
11,700
-4,400
| -27% | -$61.5K | ﹤0.01% | 10046 |
|
|
2023
Q3 | $209K | Buy |
16,100
+3,400
| +27% | +$44.1K | ﹤0.01% | 9818 |
|
|
2023
Q2 | $162K | Buy |
12,700
+11,500
| +958% | +$144K | ﹤0.01% | 10224 |
|
|
2023
Q1 | $13.5K | Sell |
1,200
-3,800
| -76% | -$46.1K | ﹤0.01% | 13361 |
|
|
2022
Q4 | $66.3K | Buy |
+5,000
| New | +$65.7K | ﹤0.01% | 11777 |
|
|
2022
Q2 | – | Sell |
-14,700
| Closed | -$284K | – | 13465 |
|
|
2022
Q1 | $284K | Buy |
+14,700
| New | +$263K | ﹤0.01% | 10718 |
|
|
2021
Q4 | – | Sell |
-16,400
| Closed | -$274K | – | 14261 |
|
|
2021
Q3 | $274K | Buy |
16,400
+600
| +4% | +$8.97K | ﹤0.01% | 11253 |
|
|
2021
Q2 | $212K | Sell |
15,800
-5,400
| -25% | -$67.6K | ﹤0.01% | 12031 |
|
|
2021
Q1 | $253K | Sell |
21,200
-5,800
| -21% | -$70.1K | ﹤0.01% | 11205 |
|
|
2020
Q4 | $335K | Buy |
+27,000
| New | +$291K | ﹤0.01% | 8876 |
|
|
2020
Q3 | – | Sell |
-10,900
| Closed | -$152K | – | 10380 |
|
|
2020
Q2 | $152K | Sell |
10,900
-13,000
| -54% | -$177K | ﹤0.01% | 8738 |
|
|
2020
Q1 | $281K | Buy |
23,900
+9,500
| +66% | +$126K | ﹤0.01% | 7455 |
|
|
2019
Q4 | $204K | Sell |
14,400
-1,600
| -10% | -$19.6K | ﹤0.01% | 8149 |
|
|
2019
Q3 | $169K | Sell |
16,000
-14,500
| -48% | -$173K | ﹤0.01% | 8241 |
|
|
2019
Q2 | $444K | Buy |
+30,500
| New | +$432K | ﹤0.01% | 7001 |
|
|
2018
Q3 | – | Sell |
-35,800
| Closed | -$494K | – | 9455 |
|
|
2018
Q2 | $494K | Buy |
35,800
+20,300
| +131% | +$304K | ﹤0.01% | 6391 |
|
|
2018
Q1 | $258K | Buy |
15,500
+5,100
| +49% | +$78.7K | ﹤0.01% | 6969 |
|
|
2017
Q4 | $148K | Buy |
+10,400
| New | +$139K | ﹤0.01% | 7282 |
|
|
2016
Q3 | – | Sell |
-20,700
| Closed | -$218K | – | 7457 |
|
|
2016
Q2 | $218K | Sell |
20,700
-5,600
| -21% | -$66.3K | ﹤0.01% | 5704 |
|
|
2016
Q1 | $331K | Sell |
26,300
-1,300
| -5% | -$14.3K | ﹤0.01% | 4973 |
|
|
2015
Q4 | $291K | Buy |
27,600
+22,200
| +411% | +$204K | ﹤0.01% | 5252 |
|
|
2015
Q3 | $39K | Buy |
5,400
+1,400
| +35% | +$19K | ﹤0.01% | 7747 |
|
|
2015
Q2 | $72K | Sell |
4,000
-16,100
| -80% | -$277K | ﹤0.01% | 7391 |
|
|
2015
Q1 | $316K | Sell |
20,100
-800
| -4% | -$12.1K | ﹤0.01% | 5580 |
|
|
2014
Q4 | $296K | Sell |
20,900
-24,000
| -53% | -$361K | ﹤0.01% | 5453 |
|
|
2014
Q3 | $767K | Buy |
44,900
+37,300
| +491% | +$857K | ﹤0.01% | 4056 |
|
|
2014
Q2 | $226K | Sell |
7,600
-41,668
| -85% | -$999K | ﹤0.01% | 5435 |
|
|
2014
Q1 | $1.23M | Sell |
49,268
-9,928
| -17% | -$291K | ﹤0.01% | 3181 |
|
|
2013
Q4 | $1.7M | Buy |
59,196
+5,585
| +10% | +$163K | ﹤0.01% | 2702 |
|
|
2013
Q3 | $1.77M | Sell |
53,611
-20,104
| -27% | -$625K | ﹤0.01% | 2529 |
|
|
2013
Q2 | $2.29M | Buy |
+73,715
| New | +$1.98M | ﹤0.01% | 2368 |
|
Other funds holding INVA
VPM
VCM
SCM
SFM
Citadel Advisors's INVA Position: Q1 2026 in Review
Citadel Advisors reduced its Innoviva (INVA) stake by 1.3% in Q1 2026, selling an estimated $48.2K and leaving 176,077 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4668.
Citadel Advisors first reported a position in INVA in Q2 2013 and has held it in 49 quarters since. The position peaked at $28.9M in Q2 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.
- Citadel Advisors held 176,077 shares of Innoviva worth $4.1M as of Q1 2026.
- Citadel Advisors sold 2,237 Innoviva shares in Q1 2026, an estimated $48.2K.
- Innoviva made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4668 holding.
- Citadel Advisors first reported a position in Innoviva in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Innoviva position peaked at $28.9M in Q2 2025.
- 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.